Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
The CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study) demonstrated that anti-inflammatory therapy reduced the incidence of MACEs by 15% in atherosclerosis patients without affecting lipid levels
Baseline (before starting GLP-1 or supplements): 25-hydroxyvitamin D (target: 30-50 ng/mL) Vitamin B12 (target: above 400 pg/mL) Serum iron, ferritin, and TIBC Serum magnesium Serum zinc Complete metabolic panel CBC (to check for anemia) Follow-up testing at 3 and 6 months: Repeat all baseline labs Add: body composition measurement (DEXA scan is gold standard) to track lean mass vs fat mass changes Assess supplement adherence and adjust doses based on results The cost of basic nutritional bloodwork is minimal compared to the cost of undiagnosed deficiencies
SKU : 75512
The emergence of GLP-1 agonists like Ozempic is not only reshaping the landscape of weight management and diabetes treatment but also holds promise in addressing alcohol consumption and addiction
